Ranpak Holdings financials
$4.37+0.46%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $395.0M | $368.9M | $336.3M | $326.5M | $383.9M | $298.2M | $269.5M |
| Gross profit | $130.7M | $139.8M | $123.3M | $99.6M | $148.9M | $122.6M | $110.9M |
| Gross margin | 33.1% | 37.9% | 36.7% | 30.5% | 38.8% | 41.1% | 41.2% |
| Operating income | -$19.8M | -$7.2M | -$2.3M | -$47.0M | $12.2M | $13.9M | $9.9M |
| Net income | -$38.3M | -$21.5M | -$27.1M | -$41.4M | -$2.8M | -$23.4M | -$17.2M |
| Net margin | −9.7% | −5.8% | −8.1% | −12.7% | −0.7% | −7.8% | −6.4% |
| Diluted EPS | $-0.45 | $-0.26 | $-0.33 | $-0.51 | $-0.04 | $-0.32 | $-0.31 |
| EBITDA | $51.0M | $61.7M | $70.3M | $28.5M | $85.0M | $74.9M | $69.9M |
| Operating cash flow | $23.1M | $41.4M | $52.6M | $1.1M | $54.3M | $63.8M | $26.3M |
| Free cash flow | -$7.2M | $8.3M | -$2.7M | -$43.7M | -$200.0K | $31.5M | -$3.4M |
| Diluted shares | 84.2M | 83.1M | 82.4M | 81.9M | 78.5M | 72.4M | 55.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $63.0M | $76.1M | $62.0M | $62.8M | $103.9M | $48.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $401.9M | $406.4M | $400.3M | $393.0M | $401.4M | $433.2M |
| Total assets | $1.12B | $1.10B | $1.12B | $1.13B | $1.21B | $1.13B |
| Total liabilities | $590.0M | $556.1M | $550.7M | $520.7M | $577.2M | $610.6M |
| Shareholders' equity | $534.9M | $548.1M | $572.0M | $612.8M | $636.2M | $522.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology